3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
35
Advanced Solid Tumors
20
Carcinoma, Non-Small-Cell Lung
14
Myelodysplastic Syndromes
13
Breast Neoplasms
13
Advanced Solid Tumor
13
Recurrence
10
Ovarian Neoplasms
8
Neoplasms
8
Multiple Myeloma
8
Leukemia, Myelomonocytic, Chronic
8
Triple Negative Breast Neoplasms
7
Solid Tumor
6
Myeloproliferative Disorders
6
Small Cell Lung Carcinoma
5
Prostatic Neoplasms
5
Neoplasm Metastasis
5
Lung Neoplasms
5
Carcinoma, Hepatocellular
5
Advanced Solid Tumour
5
Sarcoma
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Melanoma
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, B-Cell
4
Fallopian Tube Neoplasms
4
Colorectal Neoplasms
4
Advanced Malignant Solid Tumor
4
Advanced Lung Cancer
4
Squamous Cell Carcinoma of Head and Neck
3
Interventions
venetoclax
4
Azacitidine
4
Specimen Handling
3
regorafenib
1
iadademstat
1
fludarabine phosphate
1
fludarabine
1
decitabine and cedazuridine drug combination
1
Whole-Body Irradiation
1
Vorinostat
1
Thiotepa
1
Tacrolimus
1
Methotrexate
1
Lenalidomide
1
Cyclophosphamide
1
Busulfan
1
Bone Marrow Transplantation
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
GATA2 Deficiency
×
Injections
×
1 year
×
Clear all
No trials found.